- Home
- FBLG vs LGCL Comparison
FBLG vs LGCL Comparison
Compare FBLG & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLG
- LGCL
- Stock Information
- Founded
- FBLG 2021
- LGCL 2009
- Country
- FBLG United States
- LGCL China
- Employees
- FBLG N/A
- LGCL N/A
- Industry
- FBLG
- LGCL
- Sector
- FBLG
- LGCL
- Exchange
- FBLG NYSE
- LGCL NYSE
- Market Cap
- FBLG 37.1M
- LGCL 43.2M
- IPO Year
- FBLG 2024
- LGCL 2024
- Fundamental
- Price
- FBLG $0.86
- LGCL $0.45
- Analyst Decision
- FBLG Strong Buy
- LGCL
- Analyst Count
- FBLG 4
- LGCL 0
- Target Price
- FBLG $13.00
- LGCL N/A
- AVG Volume (30 Days)
- FBLG 144.4K
- LGCL 186.0K
- Earning Date
- FBLG 05-13-2025
- LGCL 11-22-2024
- Dividend Yield
- FBLG N/A
- LGCL N/A
- EPS Growth
- FBLG N/A
- LGCL 11.49
- EPS
- FBLG N/A
- LGCL 0.07
- Revenue
- FBLG N/A
- LGCL $145,690,427.00
- Revenue This Year
- FBLG N/A
- LGCL N/A
- Revenue Next Year
- FBLG N/A
- LGCL N/A
- P/E Ratio
- FBLG N/A
- LGCL $7.14
- Revenue Growth
- FBLG N/A
- LGCL N/A
- 52 Week Low
- FBLG $0.86
- LGCL $0.42
- 52 Week High
- FBLG $13.59
- LGCL $3.76
- Technical
- Relative Strength Index (RSI)
- FBLG 35.97
- LGCL N/A
- Support Level
- FBLG $0.90
- LGCL N/A
- Resistance Level
- FBLG $1.16
- LGCL N/A
- Average True Range (ATR)
- FBLG 0.08
- LGCL 0.00
- MACD
- FBLG 0.01
- LGCL 0.00
- Stochastic Oscillator
- FBLG 12.08
- LGCL 0.00
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.